Clinical Trial
Somatosensory evoked potential: an objective indicator of the therapy efficacy of a new psychotropic drug, clorazepate dipotassium (tranxene)
- PMID: 4629305
Item in Clipboard
Clinical Trial
Somatosensory evoked potential: an objective indicator of the therapy efficacy of a new psychotropic drug, clorazepate dipotassium (tranxene)
Curr Ther Res Clin Exp.
1972 Aug.
No abstract available
Similar articles
-
Digital computer analyzed sleep electroencephalogram (sleep prints) in predicting anxiolytic properties of clorazepate dipotassium (tranxene).Curr Ther Res Clin Exp. 1972 Aug;14(8):415-27. Curr Ther Res Clin Exp. 1972. PMID: 4344419 Clinical Trial. No abstract available.
-
Clorazepate dipotassium, tranxene: anti-anxiety and antidepressant activity.Res Commun Chem Pathol Pharmacol. 1973 Jan;5(1):128-34. Res Commun Chem Pathol Pharmacol. 1973. PMID: 4631197 No abstract available.
-
Clorazepate dipotassium in anxiety: a double-blind trial with diazepam controls.Curr Ther Res Clin Exp. 1972 Aug;14(8):442-8. Curr Ther Res Clin Exp. 1972. PMID: 4629306 Clinical Trial. No abstract available.
-
Evoked potentials and psychopathology.Proc Annu Meet Am Psychopathol Assoc. 1969;58:22-53. Proc Annu Meet Am Psychopathol Assoc. 1969. PMID: 4898737 Review. No abstract available.
-
New drugs of 1972.Am J Pharm Sci Support Public Health. 1973 Jan;145(1):5-16. Am J Pharm Sci Support Public Health. 1973. PMID: 4575680 Review. No abstract available.
Cited by
-
Neuropharmacological profile of clobazam, a new 1',5'-benzodiazepine.Psychopharmacology (Berl). 1978 Jun 15;58(1):27-33. doi: 10.1007/BF00426786. Psychopharmacology (Berl). 1978. PMID: 27836
-
Effect of tricyclic antidepressants on the somatosensory evoked potential in man.Psychopharmacologia. 1973 Feb 27;29(1):1-12. doi: 10.1007/BF00421206. Psychopharmacologia. 1973. PMID: 4695204 Clinical Trial. No abstract available.